Filing
Spy
Filing
Spy
Home
About
IDIX
Idenix Pharmaceuticals Inc
Biopharmaceutical company developing antiviral treatments
CUSIP: 45166R204
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2013 Q3
4 of 7 quarters
Total Value
$153.97M
Total Shares
29.67M
Net Share Change
+2.90M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$153.97M
29.67M
4.4%
ADD
+2.90M
(+10.8%)
Baupost Group LLC
$153.97M
29.67M shares
ADD
+2.90M
(+10.8%)
IDIX — Idenix Pharmaceuticals Inc - FilingSpy